Can nutrition influence circadian rhythm and heart rate variability?

Biomedicine and Pharmacotherapy

Volumn 55, Issue SUPPL.1, 2000, Pages 115-124

  Singh, R B ^a   Weydahl, A ^a   Otsuka, K ^a   Watanabe, Y ^a   Yano, S ^a   Mori, H ^a   Ichimaru, Y ^a   Mitsutake, G ^a   Sato, Y ^a   Fanghong, L ^a   Zhao, Z Y ^a   Kartik, C ^a   Gvozdjakova, A ^a  

^a Medical Hospital and Research Centre Moradabad   (India)

Author keywords

Blood pressure variability; Circadian rhythm; Heart rate variability; Nutrition

Indexed keywords

EID: 10644246149     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0753-3322(01)90016-2     Document Type: Article

References (114)

1. Airaksinen KEJ, Ikaheimo MJ, Huikuri HV, et ai. Responses of heart rate variability to coronary occlusion during coronary angioplastry. Am J Cardiol 1993 ; 72 : 1026-30.
2. Airaksinen KEJ, Ikaheimo MJ, Linnaluoto MK, et al. Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion. J Am Coll Cardiol 1998 ; 31 : 301-6.
3. Airaksinen KEJ, Ylitalo A, Niemela M, et al. Heart rate variability and occurrence of ventricular arrhythmias during abrupt coronary occlusion. Am J Cardiol 1999 ; 83 : 1000-5.
4. Atharveda S. In: Whitney WD, Ed. Atharveda Samhita, 3000-5000 BC. Motilal Banarsidass, Delhi: Charles Pockwell, Lanman, Harvard Oriental Series; 1984.
5. Becker RC, Corrao JM. Circadian variations in cardiovascular disease. Clev Clin J Med 1989 ; 56 : 676-80.
6. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984 ; 226 : 180-2.
7. Bernardi L, Wdowczyk-Szulc J, Valenti C, Castoldi S, Passino C, Spadacini G, et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol 2000 ; 35 : 1462-9.
8. Bigger JT, Fleish JL, Steinman RC, Rolnitzsky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992 ; 85 : 164-71.
9. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk of late myocardial infarction. J Am Coll Cardiol 1993 ; 21 : 729-36.
10. Bigger JT, Steinman RC, Rolnitzky LM, et al. Power law behavior of R-R-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction and patients with heart transplants. Circulation 1996 ; 93 : 2142-51.
11. Bloch-Thomsen P- E, Huikuri H, Kober L, et al. Lessons from the nordic ICD pilot study. Lancet 1999 ; 353 : 2130-2.
12. Block KD, Krenzenbeck W. Spontaneous blood pressure variations in hypertension. In: Gross F, Ed. Antihypertensive therapy: an international symposium. New York: Springer Verlag; 1966. p. 224-41.
13. Bonnemier H, Hartmann F, Wiegant UK, Irmer C, Kurz T, Tolg R, et al. Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplastry. Am J Cardiol 2000 ; 85 : 815-20.
14. Braunwald E. Unstable angina: an etiologic approach to management. Circulation 1998 ; 98 : 2219-22.
15. Camm AJ, Karam R, Pratt CM. The azimilide post-infarct survival evaluation (ALIVE) trial. Am J Cardiol 1998 ; 81 : 35D-9D.
16. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969 ; 223 : 1159-61.
17. Charaka S. In: Sharma PV, Ed. Transi. Charaka Samhita, 600 BC [translation]. Varanasi, Delhi: Chaukhambha Orientalia; 1981.
18. Chen CH, Cornelissen G, Halberg F et al. Elevated left ventricular mass index in circadian-hyper-amplitude tension (CHAT). Scripta Med (in press).
19. Chen CH, Ting CT, Lin SJ, Itsu TL, Chuo P, Kuo HS, et al. Relation between diurnal variation of blood pressure and left ventricular mass in a Chinese population. Am J Cardiol 1995 ; 75 : 1239-43.
20. Chin JPF. Marine oils and cardiovascular reactivity. Prostaglandins Leukotrienes Essent Fatty Acids 1994 ; 50 : 211-22.
21. Christ M, Seyffart K, Wehling M. Attenuation of heart rate variability in postmenopausal women on progestin containing hormone replacement therapy. Lancet 1999 ; 353 : 1939-40.
22. Christensen JH, Christensen MS, Toft E, Dyerberg J, Schmidt EB. Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis 2000 ; 10 : 57-61.
23. Christensen JH, Gustenhoff P, Komp E, Aaroe J, Tofgt E, Moller J, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction. Br Med J 1996 ; 312 : 677-8.
24. Christensen JH, Komp E, Aaroe J, Toft E, Moller J, Rasmusen K, et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997 ; 79 : 1670-2.
25. Churisna SK, Ganelina LE. On the distribution of incidence of acute myocardial infarction within a 24-hour period. Kardiologia 1975 ; 15 : 115-8.
26. Cohen MC, Rohtla KM, Lavary CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997 ; 79 : 1512-6.
27. Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a 2-year follow-up study. J Am Coll Cardiol 1996 ; 27 : 270-6.
28. Cugini P, Letizia C, Scarvo D. The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with circadian cycle of plasma renin and aldosterone. Chronobiologia 1988 ; 15 : 229-32.
29. Cugini P, Scibilia G, Cavallini M, Letizia C, et al. Circadian rhythms of renin activity, aldosterone, angiotensin converting enzyme and cortisol in kidney and heart transplantation. Chronbiology, Part A. New York/London: Wiley-Liss Inc.; 1990. p. 565-74.
30. Duru F, Candinas R, Dziekan G, Goebbels U, Myers J, Dubach P. Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction. Am Heart J 2000 ; 140 : 157-61.
31. Epstein AE, Carlson MD, Fogoros RN, et al. Classification of death in anti-arrhythmia trials. J Am Coll Cardiol 1996 ; 27 : 433-42.
32. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991 ; 18 : 687-97.
33. Feign VL, Nikitin YP, Vinogrodova TE. Solar and geomagnetic activities: are there associations with stroke occurrence? Cerebrovasc Dis 1997 ; 7 : 345-8.
34. Franzosi MG, Sanforo E, de Vita C, et al. Ten-year follow up of the first mega-trial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998 ; 15 : 2659-65.
35. Gallerani M, Portaluppi F, Maida G, et al. Circadian and circaannual rhythmicity in the occurrence of subarachnoid haemorrhage. Stroke 1996 ; 27 : 1793-7.
36. Garcia-Gonzalez MA, Vazquez-Seisdedos C, Pallas-Areny R. Variations in breathing patterns increase low frequency contents in HRV spectra. Physiol Meas 2000 ; 21 : 417-23.
37. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, et al. Ambient pollution and heart rate variability. Circulation 2000 ; 101 : 1267-73.
38. Goldberger AL. Non-linear dynamics for clinicians theory, fractals and complexity at the bedside. Lancet 1996 ; 347 : 1312-4.
39. Goldberger AL, West BJ. Fractals in physiology and medicine. J Biol Med 1987 ; 60 : 421-35.
40. Goldman S, Johnson G, Cohn JN, et al. Mechanism of death in heart failure: the Vasodilator-Heart Failure Trials. Circulation 1993 ; 87 (Suppl 6) : VI24-33.
41. Goldman S, Johnson G, Cohn JN, et al. Mechanism of death in heart failure: the Vasodilator-Heart Failure Trials. Circulation 1993 ; 87 (Suppl 6) : VI24-33.
42. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med 1989 ; 225 (Suppl) : 117-28.
43. Halberg F, Cornelissen G, Halberg J, Fink H, Chen CH, Otsuka K, et al. Circadian hyper-amplitude-tension. CHAT; a disease risk syndrome of anti-aging medicine. J Am Med Assoc 1998 ; 1 : 239-59.
44. Halberg F, Cornelissen G, Otsuka K, Watanabe Y, et al. Cross-spectrally coherent 10.5 and 21 year biological and physical cycles, magnetic storms and myocardial infarctions. Neuroendocrinol Lett 2000 ; 21 : 233-58.
45. Hartikainen JEF, Malik M, Staunton A, et al. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996 ; 28 : 296-304.
46. Hedblad B, Juul MS, Svensson K, et al. Increased mortality in men with ST segment depression during 24-hour ambulatory long-term ECG recording. Eur Heart J 1989 ; 10 : 149-58.
47. Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary artery disease. Arterioscler Thromb Vase Biol (in press).
48. Huikuri HV, Koistinen MJ, Yli-Mayry S, et al. Impaired low frequency oscillations of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. Am J Cardiol 1995 ; 76 : 56-60.
49. Huikuri HV, Makikallio TH, Airaksinen KEJ, et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998 ; 97 : 2030-6.
50. Huikuri HV, Seppanen T, Koistinen MJ, et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation 1996 ; 93 : 1836-44.
51. Kaplan JR, Manuck SB. Adams MR, et al. Inhibition of coronary atherosclerosis by propranolol on behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987 ; 86 : 1364-74.
52. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharm 1987 ; 10 (Suppl2) : S100-S2.
53. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, for the Multicentre Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987 ; 59 : 256-62.
54. Korkmaz ME, Muderrisoglu H, Ulucam Ozin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol 2000 ; 86 : 649-53.
55. Kruger C, Landerer V, Zugck C, Ehmke H, Kubler W, Haass M. The bradycardic agent zatebrandine enhances barore-flex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc Res 2000 ; 45 : 900-12.
56. Kukreja RS, Datta BN, Chakravarti RN. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 1981 ; 40 : 291-8.
57. Kumagai Y, Shiga T, Sunaga K, Cornelissen G, Ebihara A, Halberg F. Usefulness of circadian amplitude of blood pressure in predicting hypertensive cardiac involvement. Chronobiologia 1992 ; 19 : 43-58.
58. La Rovere MT, Bigger Jr, Marcus FI. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998 ; 351 : 478-84.
59. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998 ; 351 : 478-84.
60. 123I-metaiodobenzylguanidine scintigraphic uptake and heart rate variability in patients with syndrome X. Ital Heart J 2000 ; 1 : 221-5.
61. Lucreziotti S, Gavazzi A, Scelsi L, Inserra C, Klersy C, Campana C, et al. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J 2000 ; 139 : 1088-95.
62. Makikallio TH, Koistinen MJ, Tulppo MP, et al. R-R interval dynamics before the spontaneous onset of ventricular fibrillation. Am J Cardiol 1999 ; 83 : 880-4.
63. Makikallio TH, Ristimae T, Airaksinen EKJ, et al. Heart rate dynamics in patients with stable angina pectoris and utility of fractal and complexity measures. Am J Cardiol 1998 ; 81 : 27-31.
64. Malik M, Camm AJ, Janse MJ, Julian DJ, et al. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a sub-study of EMIAT Eur Myocardial Infarct Amiodarone Trial. J Am Coll Cardiol 2000 ; 35 : 1263-75.
65. Malik M, Hnatkova K, Camm AJ. Practicality of post-infarction risk assessment based on time-domain measurement of heart rate variability. In: Malik M, Camm AJ, Eds. Heart rate variability. Armonk, NY: Futura; 1995. p. 393-406.
66. Manfredini R, Gallerani M, Portaluppi F, Salmi R, Fesim C. Chronobiological patterns of onset of acute cerebrovascular disease. Thromb Res 1997 ; 88 : 451-63.
67. Mehta SR, Das S, Karloopia SD, Mathur P, Dham SK, Raghunathan D. The circadian pattern of ischaemic heart disease in Indian population. J Assoc Phys India 1998 ; 46 : 767-77.
68. Melanson EL. Resting heart rate variability in men varying in habitual physical activity. Med Sci Sports Ex 2000 ; 32 : 1894-901.
69. Morris K. New day dawns for research on circadian rhythms. Lancet 1999 ; 353 : 990.
70. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroreflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 2000 ; 36 : 1612-8.
71. Muller JE, Befier GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989 ; 4 : 733-40.
72. Muller JE, Stone PH, Zoltan G, et al. The MILIS study groups; circadian variation in the frequency onset of acute myocardial infarction. N Engl J Med 1985 ; 313 : 1315-22.
73. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992 ; 85 (Suppl 1) : 112-120.
74. Nisam S, Mower M. ICD trials: an extraordinary means of determining patients risk? PACE 1998 ; 21 : 1341-6.
75. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998 ; 98 : 1510-6.
76. Otsuka K, Cornelissen G, Halberg F, et al. Predictive value of blood pressure dipping and swinging with regard to vascular disease risk. Clin Drug Invest 1996 ; 11 : 20-31.
77. Otsuka K, Cornelissen G, Halberg F, Oehlert G. Excessive circadian amplitude increases risk of ischaemic stroke and nephropathy. J Med Eng Tech 1997 ; 21 : 23-30.
78. Otsuka K, Cornelissen G, Halberg F. Age, gender and fractal scaling in heart rate variability. Clin Sci 1997 ; 93 : 299-308.
79. Otsuka K, Cornelissen G, Halberg F. Circadian rhythmic scaling of heart rate variability in health and coronary artery dis-z ease. Clin Cardiol 1997 ; 20 : 631-8.
80. Otsuka K, Ed. Chronome and Janus-medicine. Heart rate variability (HRV) and BP variability (BPV) from a view point of chronobiology and ecology. Tokyo: Medical Review; 1998. p. 213.
81. Paolisso G, Manzella D, Montano N, Gambardella A, Varrichio M. Plasma leptin concentrations and cardiac automic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 2000 ; 85 : 1810-4.
82. Paolisso G, Manzella D, Rizzo MR, Ragno E, Barieri M, Varricchio G, et al. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr 2000 ; 72 : 723-30.
83. Pell S, D'Allonzo CA. Acute myocardial infarction in a large industrial population. J Am Med Assoc 1963 ; 185 : 831-8.
84. Pepe S, Bogdonor K, Hallaq H, Spurgeon H, Leaf A, Lakatta E. Omega-3 polyunsaturated fatty acids modulates dihydropyridine effects on L-type Ca-channels, cytosolic Ca and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci U S A 1994 ; 91 : 8832-6.
85. Perini R, Milesi S, Fisher NM, Pendergast DR, Veicsteinas A. Heart rate variability during dynamic exercise in elderly males and females. Eur J Appl Physiol 2000 ; 82 : 8-15.
86. Perkiomaki JS, Huikuri HV, Koistinen JM, et al. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. J Am Coll Cardiol 1997 ; 30 : 1331-8.
87. Peters RW, Zoble RG, Liebson PR, et al. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: past experience. J Am Coll Cardiol 1993 ; 2 : 998-1003.
88. Pruvat E, Thonet G, Vesin JM, et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000 ; 101 : 2398-404.
89. Rosano GM, Partrizi R, Leonardo F, Ponikowski P, Collins P, Sarrel PM, et al. Effect of oestrogen replacement therapy in heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1996 ; 80 : 815-7.
90. Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with a healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 1984 ; 69 : 780-90.
91. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992 ; 85 (Suppl 1) : 77-91.
92. Shusterman V, Aysin B, Gottipaty V, et al. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. J Am Coll Cardiol 1998 ; 32 : 1891-9.
93. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study. Am J Cardiol 2000 ; 86 : 309-11.
94. Singh RB, Niaz MA, Kartikey K, Cornelissen G, Halberg F, Otsuka K, et al. Prevalence and determinants of blood pressure variability in a population of north India. (Submitted).
95. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction. The Indian experiment of infarct survival. Cardiovasc. Drug Ther 1997 ; 11 : 485-91.
96. Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharama JP, et al. Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc. Drug Ther 1998 ; 12 : 347-53.
97. Singh RB. Can nutrition influence heart rate and blood pressure variability? [Abstract]. Proceedings, First International Symposium on Chronoastrobiology and Chronotherapy, Tokyo, November 11, 2000. p. 99.
98. Soejima K, Akaishi M, Meguro T, Oyamada K, Yoshikawa T, Mitamura H, et al. Age-adjusted heart rate variability as an index of the severity and prognosis of heart failure. Jpn Circ J 2000 ; 64 : 32-8.
99. Stein PK, Domitrovich PP, Kleiger RE, Schechtman KB, Rottman JN. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the Cardiac Arrhythmia Suppression Trial (CAST). Clin Cardiol 2000 ; 23 : 187-94.
100. Sushruta S. In: Bhisgratne C, Ed. Trans. Sushruta Samhita, 600 BC, Vol. 1-3 [translation]. Varanasi: Delhi: Sanskrit Series Office; 1999.
101. Tamura K, Kohna I, Saito Y, Wakasugi K, Achiwa S, Imanishi Y, et al. Antihypertensive individualized therapeutic strategy. Dif Soc 1991 ; 6 : 109-24.
102. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation and clinical use. Circulation 1996 ; 93 : 1043-65.
103. Thombson DR, Blandford RL, Sutton TW, Merchant PR. Time onset of chest pain in acute myocardial infarction. Int J Cardiol 1985 ; 7 : 139-46.
104. Toffer GH, Brezinski DA, Schafer HI, Czesler CA, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Eng J Med 1987 ; 316 : 1514-8.
105. Tsuiji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996 ; 94 : 2850-5.
106. Tsuiji H, Venditti FJ, Manders ES, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994 ; 90 : 878-83.
107. Vaidya AB, Bhatt MA. Chronobiology of ischaemic heart disease events: relevance of ancient insights in human lifestyle. J Assoc Phys India 1999 ; 47 : 629-30.
108. Valkama JO, Huikuri HV, Koistinen MJ, et al. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 1995 ; 25 : 437-43.
109. Veglio F, Pitrandice R, Ossola M, Vignani A, Angili A. Circadian rhythm of the angiotensin converting enzyme activity in serum of healthy adult subjects. Chronobiologia 1997 ; 14 : 21-5.
110. Vybiral T, Glaeser DH, Goldberger AL, et al. Conventional heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation. J Am Coll Cardiol 1993 ; 22 : 557-65.
111. Watanabe Y, Cornelissen G, Halberg F, Saito Y, Fukuda K, Otsuka K, et al. Chronobiometric assessment of autogenic training effects upon blood pressure and heart rate. Percept Motor Skills 1996 ; 83 : 1395-410.
112. WHO International Study Group. Myocardial infarction community register. In: Public health in europe. Copenhagen: Regional Office for Europe; 1976 ; 5 : 1-232.
113. Willich SN, Goldberg JG, Maclure M, Petrriello I, Muller JE. Increased onset of sudden cardiac death in the first 3 hours after awakening. Am J Cardiol 1992 ; 70 : 65-8.
114. Zuanetti G, Neilson JMM, Latini R, et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation 1996 ; 94 : 432-6.